Poster: PK/PD, Safety, and Efficacy Platforms
Learn More
Bispecific Antibodies
From ideal models to translationally relevant data, learn more about JAX's bispecific antibody services and how we can help you move from PK/PD to efficacy and toxicity evaluation.
-
-
Case Study: PK/PD, Safety, and Efficacy Platforms
Read Flipbook
-
JAX Live! Bispecific Antibody Testing
Watch Video
-
Loading, please wait
Error - something went wrong!
Contact us for more information on our bispecific antibody services
Thank you, we will reach out soon!
-
Poster: CRS and Efficacy using a BCMAxCD3 bispecific antibody
Learn More
-
Case Study: CRS and Efficacy using a BCMAxCD3 Bispecific Antibody
Read Flipbook
-
Improve Antibody Half-Life Measurements
Learn More
-
Poster: Evaluation of Bispecific Antibody Efficacy and Drug-Induced Cytokine Release
Learn More
-
Case Study: Evaluation of Bispecific Antibody Efficacy and Drug-Induced Cytokine Release
Read Flipbook
-
An In Vivo Model to Evaluate Donor-Dependent Cytokine Release
Watch Video
